| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ONCOBIOLOGICS INC - WARRANT B | 96,833 | 48,000 | 0.01% | ||
| 2 | ONCOBIOLOGICS INC - WARRANT A | 96,833 | 77,000 | 0.02% | ||
| 3 | ONCOBIOLOGICS INC | 29,082 | 78,000 | 0.02% | ||
| 4 | QUOTIENT LTD | 18,900 | 132,000 | 0.03% | ||
| 5 | LION BIOTECHNOLOGIES INC COM | 40,000 | 298,000 | 0.07% | Call | |
| 6 | XBIOTECH INC | 20,000 | 330,000 | 0.08% | Put | |
| 7 | OMEROS CORP | 30,000 | 454,000 | 0.11% | Call | |
| 8 | INVITAE CORP | 50,000 | 553,000 | 0.13% | Call | |
| 9 | AEHR TEST SYSTEMS | 122,000 | 587,000 | 0.14% | ||
| 10 | INVITAE CORP | 70,000 | 774,000 | 0.18% | Put | |
| 11 | CONCERT PHARMACEUTICALS INCORPORATED | 49,051 | 837,000 | 0.20% | ||
| 12 | ROCKWELL MED INC | 140,000 | 876,000 | 0.21% | Put | |
| 13 | Progenics Pharmaceuticals Inc | 100,000 | 944,000 | 0.22% | ||
| 14 | XBIOTECH INC | 60,000 | 989,000 | 0.23% | Call | |
| 15 | ADVISORY BRD CO COM | 21,300 | 997,000 | 0.24% | ||
| 16 | VERSARTIS INC | 49,100 | 1,048,000 | 0.25% | Put | |
| 17 | DBV TECHNOLOGIES S A | 30,000 | 1,057,000 | 0.25% | Call | |
| 18 | ARRAY BIOPHARMA INC | 120,500 | 1,077,000 | 0.26% | Call | |
| 19 | ZOGENIX INC | 100,000 | 1,085,000 | 0.26% | Put | |
| 20 | VERACYTE INC | 130,000 | 1,193,000 | 0.28% | Call | |
| 21 | SYNERON MEDICAL LTD | 122,400 | 1,291,000 | 0.31% | ||
| 22 | ALIMERA SCIENCES INC | 974,318 | 1,364,000 | 0.32% | ||
| 23 | CLEARSIDE BIOMEDICAL INC | 175,000 | 1,390,000 | 0.33% | ||
| 24 | Progenics Pharmaceuticals Inc | 150,000 | 1,416,000 | 0.34% | Put | |
| 25 | SAGE THERAPEUTICS INC | 20,000 | 1,421,000 | 0.34% | Put | |
| 26 | Evolent Health, Inc. | 80,000 | 1,784,000 | 0.42% | Call | |
| 27 | NEKTAR THERAPEUTICS COM | 76,600 | 1,798,000 | 0.43% | Put | |
| 28 | ESSA Pharma | 605,300 | 1,876,000 | 0.44% | ||
| 29 | MARVELL TECHNOLOGY GROUP LTD | 147,500 | 2,251,000 | 0.53% | Call | |
| 30 | CORBUS PHARMACEUTICALS HLDGS | 290,000 | 2,393,000 | 0.57% | Put | |
| 31 | CLOVIS ONCOLOGY INC | 40,361 | 2,570,000 | 0.61% | ||
| 32 | BIOCRYST PHARMACEUTICALS | 325,000 | 2,730,000 | 0.65% | Call | |
| 33 | AURINIA PHARMACEUTICALS INC | 400,000 | 2,936,000 | 0.70% | ||
| 34 | IMMUNOMEDICS INCORPORATED | 503,000 | 3,254,000 | 0.77% | ||
| 35 | NANOSTRING TECHNOLOGIES INC | 164,932 | 3,277,000 | 0.78% | ||
| 36 | Evolent Health, Inc. | 150,000 | 3,345,000 | 0.79% | ||
| 37 | MEDICINES CO | 70,000 | 3,423,000 | 0.81% | ||
| 38 | NEURODERM LTD | 150,000 | 3,983,000 | 0.94% | Call | |
| 39 | ANAPTYSBIO INC | 165,690 | 4,138,000 | 0.98% | ||
| 40 | AVEXIS INC COM | 56,000 | 4,258,000 | 1.01% | ||
| 41 | VIEWRAY INC COM USD0.01 | 601,073 | 4,637,000 | 1.10% | ||
| 42 | ZOGENIX INC | 437,113 | 4,743,000 | 1.12% | ||
| 43 | JOHNSON & JOHNSON | 40,000 | 4,982,000 | 1.18% | Put | |
| 44 | ASSEMBLY BIOSCIENCES INC | 200,000 | 5,098,000 | 1.21% | Call | |
| 45 | DBV TECHNOLOGIES S A | 149,690 | 5,272,000 | 1.25% | ||
| 46 | RA PHARMACEUTICALS INC COM | 247,956 | 5,279,000 | 1.25% | ||
| 47 | MARVELL TECHNOLOGY GROUP LTD | 350,000 | 5,341,000 | 1.27% | ||
| 48 | TESARO INCORPORATED | 35,000 | 5,385,000 | 1.28% | ||
| 49 | ACLARIS THERAPEUTICS INC COM | 200,000 | 5,964,000 | 1.41% | ||
| 50 | Oxford Immunotec Global PLC | 386,100 | 5,981,000 | 1.42% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001493152-17-005200, filed 2017.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
